Hansjoerg Wyss

About Hansjoerg Wyss

Hansjoerg Wyss' fortune stems from his 2012 sale of medical device manufacturer Synthes, which he founded, to Johnson & Johnson for $20.2 billion.

He now holds stakes in publicly traded biotech companies NovoCure and Molecular Partners.

One of the most philanthropic people in the world, Wyss also has charitable foundations with assets of over $2 billion.

In 2022, he pledged $350 million to the Wyss Institute for Biologically Inspired Engineering at Harvard, where he had already made pledges totaling $381 million since 2009.

In 2018, Wyss' foundation pledged $1 billion for conservation efforts over a decade. It upped its pledge to $1.5 billion in 2021.